With this work we contribute to the molecular dissection of the CLCN7 deficient ARO and provide new insights into the molecular bases of the disease which can be exploited for the molecular diagnosis of malignant osteopetrosis with an inconsistent clinical history and a not clear phenotype. This evidence concerns the gene CLCN7 and osteopetrosis.